Home > Boards > US Listed > Medical - Healthcare > Acasti Pharma, Inc (ACST)

News: $ACST Acasti Pharma Releases Preliminary Data for

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 55
Posts 6,970
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia... GlobeNewswire Inc. - 11/26/2019 7:55:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/18/2019 8:47:08 AM
Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes GlobeNewswire Inc. - 11/18/2019 8:38:28 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/13/2019 7:56:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/13/2019 7:55:59 AM
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020 GlobeNewswire Inc. - 11/13/2019 7:55:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/7/2019 8:43:15 AM
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal GlobeNewswire Inc. - 11/7/2019 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/6/2019 9:40:07 AM
Acasti Pharma Schedules Second Quarter Fiscal 2020 Conference Call GlobeNewswire Inc. - 11/6/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/4/2019 9:25:45 AM
Acasti Pharma Partners with Aker BioMarine to Supply Krill Oil for CaPre® GlobeNewswire Inc. - 11/4/2019 9:04:06 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/1/2019 9:01:17 AM
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire Inc. - 10/1/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/30/2019 8:37:48 AM
Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 i... GlobeNewswire Inc. - 9/30/2019 8:35:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/9/2019 8:42:19 AM
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity GlobeNewswire Inc. - 9/9/2019 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/4/2019 9:01:16 AM
Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th GlobeNewswire Inc. - 9/4/2019 9:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/28/2019 4:06:14 PM
Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Re... GlobeNewswire Inc. - 8/28/2019 4:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2019 8:01:16 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/14/2019 8:01:11 AM
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020 GlobeNewswire Inc. - 8/14/2019 8:00:00 AM
whytestocks Member Level  Monday, 11/18/19 10:19:25 PM
Re: None
Post # of 548 
News: $ACST Acasti Pharma Releases Preliminary Data for CaPre in Diabetic Mice

Acasti Pharma (NASDAQ: ACST ,TSXV:ACST) kickstarted the week by releasing preliminary data on Monday (November 18) from a preclinical mouse study evaluating its hypertriglyceridemia (HTG) drug CaPre as a potential treatment for type 2 diabetes.  CaPre demonstrated an increase in insul...

Got this from ACST - Acasti Pharma Releases Preliminary Data for CaPre in Diabetic Mice

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist